This First Solar Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
This First Solar Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
這位第一太陽能分析師轉爲看好;以下是週一的五大升級內容
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
華爾街頂級分析師改變了對這些頂級公司的展望。如需查看包括升級和降級在內的所有分析師評級變化的完整視圖,請參閱我們的分析師評級頁面。
- Citigroup analyst Renata Cabral upgraded the rating for Coca-Cola FEMSA, S.A.B. de C.V. (NYSE:KOF) from Neutral to Buy and raised the price target from $93 to $102. Coca-Cola Femsa shares closed at $84.40 on Monday. See how other analysts view this stock.
- Janney Montgomery Scott analyst Sean Milligan upgraded the rating for First Solar, Inc. (NASDAQ:FSLR) from Neutral to Buy and announced a $260 price target. First Solar shares closed at $205.03 on Monday. See how other analysts view this stock.
- Jefferies analyst Julien Dormois upgraded Koninklijke Philips N.V. (NYSE:PHG) from Underperform to Hold. Philips shares closed at $26.62 on Monday. See how other analysts view this stock.
- Raymond James analyst Steven Seedhouse upgraded ProQR Therapeutics N.V. (NASDAQ:PRQR) from Outperform to Strong Buy and boosted the price target from $6 to $14. ProQR Therapeutics shares closed at $3.31 on Monday. See how other analysts view this stock.
- Barclays analyst Adam Seiden upgraded the rating for Summit Materials, Inc. (NYSE:SUM) from Equal-Weight to Overweight and raised the price target from $45 to $52. Summit Materials shares closed at $45.63 on Monday. See how other analysts view this stock.
- 花旗集團分析師Renata Cabral將可口可樂凡薩瓶裝(NYSE:KOF)的評級從中立調高至買入,並將價格目標從93美元提高至102美元。可口可樂凡薩瓶裝週一收盤價爲84.40美元。看看其他分析師對這支股票的看法。
- Janney Montgomery Scott分析師Sean Milligan將第一太陽能公司(NASDAQ:FSLR)的評級從中立調高至買入,並宣佈260美元的價格目標。第一太陽能公司週一收盤價爲205.03美元。看看其他分析師對這支股票的看法。
- Jefferies分析師Julien Dormois將皇家飛利浦公司(NYSE:PHG)的評級從表現不佳調高至持有。飛利浦公司週一收盤價爲26.62美元。看看其他分析師對這支股票的看法。
- Raymond James分析師Steven Seedhouse將ProQR Therapeutics N.V.(NASDAQ:PRQR)的評級從跑贏市場調高至強烈買入,並將價格目標從6美元提高至14美元。proqr therapeutics週一收盤價爲3.31美元。看看其他分析師對這支股票的看法。
- 巴克萊銀行分析師Adam Seiden將Summit Materials, Inc.(NYSE:SUM)的評級從等權調高至超配,並將價格目標從45美元提高至52美元。summit materials週一收盤價爲45.63美元。看看其他分析師對這支股票的看法。
Considering buying FSLR stock? Here's what analysts think:
考慮購買FSLR股票嗎?以下是分析師的看法:
Read More:
閱讀更多:
- Jim Cramer: 'Avoid' This Consumer Cyclical Stock, Buy Lam Research
- 吉姆·克雷默:'避免'這家消費週期性股票,買入拉姆研究
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。